Advertisement for orthosearch.org.uk
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

SHORT- AND MIDTERM RESULTS OF THE UNCEMENTED, UNCONSTRAINED HM-MCP-ARTHROPLASTY IN R.A. – A MULTICENTER STUDY.

7th Congress of the European Federation of National Associations of Orthopaedics and Traumatology, Lisbon - 4-7 June, 2005



Abstract

In 85 % of the patients with rheumatoid arthritis the MCP-joints are involved with incressing deterioration an loss of function. The standard replacement of the MCP-joints using the Swanson-Silastic Spacers shows pain reduction and a realigment of the fingers, but the functional capacity is not improved.

The HM-MCP-arthroplasty offers a concept for better function an restoration of the rheumatoid hands and osteoarthritis.

In a prospective multicenter study 63 HM-MCP arthroplasties have been implanted. We used the redesigned model (PE-metacarpal head and Ti-ODH phalangeal base) with titanium stems. The follow up-time is 18 months (6 – 40 months). All patients are controlled with clinical and radiographic evaluation.

The active ROM of the MCP-joints demonstrated on average flex./ext. 65/10/0 (preop. 70/15/0). The grip strength at FU demonstrated 80 % of the untreated contralateral control hand. Pain has been improved using the verbal pain scale at 1.6 (preop. 2.1).

Radiographically all metacarpal and phalangeal stems show an osteointegration of the implants. Radio-lucent lines of < 1 mm have been detected at the phalangeal base without a sign of loosing.

Complications: 1 palmar luxation with a successful closed reposition, 1 ulnar subluxation of the fifth finger, 1 unsuccessful revised palmar luxation.

The results of the uncemented, unconstrained HM-MCP-arthroplasty show an improvement of the hand function and pain reduction. This endoprosthesis gives a new chance to treat the rheumatoid hand at an earlier stage of destruction before severe contracture of the soft tissues.

Theses abstracts were prepared by Professor Roger Lemaire. Correspondence should be addressed to EFORT Central Office, Freihofstrasse 22, CH-8700 Küsnacht, Switzerland.